Literature DB >> 20535790

Monitoring the long-term safety of therapies for children with juvenile idiopathic arthritis: time for a consolidated patient registry.

Meredith Y Smith1, Rachel E Sobel, Carol A Wallace.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20535790     DOI： 10.1002/acr.20128

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN： 2151-464X            Impact factor:   4.794


× No keyword cloud information.
  11 in total

1.  Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA?

Authors:  Randy Q Cron; Timothy Beukelman
Journal:  Pediatr Rheumatol Online J       Date:  2010-08-16       Impact factor: 3.054

2.  Rates of malignancy associated with juvenile idiopathic arthritis and its treatment.

Authors:  Timothy Beukelman; Kevin Haynes; Jeffrey R Curtis; Fenglong Xie; Lang Chen; Christina J Bemrich-Stolz; Elizabeth Delzell; Kenneth G Saag; Daniel H Solomon; James D Lewis
Journal:  Arthritis Rheum       Date:  2012-02-10

Review 3.  Infectious complications in juvenile idiopathic arthritis.

Authors:  Andrew Hurd; Timothy Beukelman
Journal:  Curr Rheumatol Rep       Date:  2013-05       Impact factor: 4.592

Review 4.  What is the background incidence of malignancy in children with rheumatic disease?

Authors:  Melissa L Mannion; Timothy Beukelman
Journal:  Curr Rheumatol Rep       Date:  2013-03       Impact factor: 4.592

Review 5.  Using registries to identify adverse events in rheumatic diseases.

Authors:  Geraldina Lionetti; Yukiko Kimura; Laura E Schanberg; Timothy Beukelman; Carol A Wallace; Norman T Ilowite; Jane Winsor; Kathleen Fox; Marc Natter; John S Sundy; Eric Brodsky; Jeffrey R Curtis; Vincent Del Gaizo; Solomon Iyasu; Angelika Jahreis; Ann Meeker-O'Connell; Barbara B Mittleman; Bernard M Murphy; Eric D Peterson; Sandra C Raymond; Soko Setoguchi; Jeffrey N Siegel; Rachel E Sobel; Daniel Solomon; Taunton R Southwood; Richard Vesely; Patience H White; Nico M Wulffraat; Christy I Sandborg
Journal:  Pediatrics       Date:  2013-10-21       Impact factor: 7.124

6.  Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis.

Authors:  Timothy Beukelman; Fenglong Xie; John W Baddley; Lang Chen; Elizabeth Delzell; Carlos G Grijalva; Melissa L Mannion; Nivedita M Patkar; Kenneth G Saag; Kevin L Winthrop; Jeffrey R Curtis
Journal:  Arthritis Rheum       Date:  2013-05

7.  Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis.

Authors:  Yukiko Kimura; Jennifer E Weiss; Kathryn L Haroldson; Tzielan Lee; Marilynn Punaro; Sheila Oliveira; Egla Rabinovich; Meredith Riebschleger; Jordi Antón; Peter R Blier; Valeria Gerloni; Melissa M Hazen; Elizabeth Kessler; Karen Onel; Murray H Passo; Robert M Rennebohm; Carol A Wallace; Patricia Woo; Nico Wulffraat
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-05       Impact factor: 4.794

8.  An i2b2-based, generalizable, open source, self-scaling chronic disease registry.

Authors:  Marc D Natter; Justin Quan; David M Ortiz; Athos Bousvaros; Norman T Ilowite; Christi J Inman; Keith Marsolo; Andrew J McMurry; Christy I Sandborg; Laura E Schanberg; Carol A Wallace; Robert W Warren; Griffin M Weber; Kenneth D Mandl
Journal:  J Am Med Inform Assoc       Date:  2012-06-25       Impact factor: 4.497

Review 9.  Systematic review of disease-modifying antirheumatic drugs for juvenile idiopathic arthritis.

Authors:  Alex R Kemper; Heather A Van Mater; Remy R Coeytaux; John W Williams; Gillian D Sanders
Journal:  BMC Pediatr       Date:  2012-03-15       Impact factor: 2.125

10.  Development and Implementation of a Registry of Patients Attending Multidisciplinary Pain Treatment Clinics: The Quebec Pain Registry.

Authors:  M Choinière; M A Ware; M G Pagé; A Lacasse; H Lanctôt; N Beaudet; A Boulanger; P Bourgault; C Cloutier; L Coupal; Y De Koninck; D Dion; P Dolbec; L Germain; V Martin; P Sarret; Y Shir; M-C Taillefer; B Tousignant; A Trépanier; R Truchon
Journal:  Pain Res Manag       Date:  2017-02-09       Impact factor: 3.037
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.